← Leaderboards
Aaron James Polichnowski
Augusta University
$1,763,750
Attributed
$2,666,750
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2011–25$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,666,750 · 3
VA$0 · 1
By mechanism
R01$1,806,000 · 1
R15$444,000 · 1
R21$416,750 · 1
IK2$0 · 1
Top collaborators
- David L. Mattson3 shared
Most similar at Augusta University
Same institution · by research overlap
- David L. Mattson$14,169,382
- Jennifer C Sullivan$9,781,431
- Tohru Fukai$10,473,455
- David J Fulton$11,867,025
- Scott A Barman$6,157,524
Others in their field
Top investigators on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$493,822,581
- Barton F Haynes · Duke University$295,802,493
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$286,700,869
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$176,977,598
- Dan H. Barouch · Fred Hutchinson Cancer Center$122,734,499
Research focus
MediatingKidneyRattusBlood PressureInsightKidney DiseasesHypertensionGlomerular Filtration RateRenal FunctionKidney Vascular StructureLeadExhibitsRisk FactorsAnimalsChronic Kidney FailureHemodynamicsChronicPathway InteractionsConsciousHypoxiaInjuryIschemiaExposure ToExperimental Study
Grant awards (10)
Gut Metabolites, T cells, and Salt-Sensitive Hypertension$629,859
R01 · FY2025 · HL
PFAS, Renal Hemodynamics, and Kidney Disease$416,750
R21 · FY2025 · ES · contact PI
Gut Metabolites, T cells, and Salt-Sensitive Hypertension$617,262
R01 · FY2024 · HL
Gut Metabolites, T cells, and Salt-Sensitive Hypertension$558,879
R01 · FY2023 · HL
Hemodynamic mechanisms of impaired recovery and progression of renal disease following AKI in preexisting CKD states$444,000
R15 · FY2020 · HL · contact PI
Nitric Oxide Deficiency in Hypertensive Nephropathies$0
IK2 · FY2015 · VA · contact PI
Nitric Oxide Deficiency in Hypertensive Nephropathies$0
IK2 · FY2014 · VA · contact PI
Nitric Oxide Deficiency in Hypertensive Nephropathies$0
IK2 · FY2013 · VA · contact PI
Nitric Oxide Deficiency in Hypertensive Nephropathies$0
IK2 · FY2012 · VA · contact PI
Nitric Oxide Deficiency in Hypertensive Nephropathies$0
IK2 · FY2011 · VA · contact PI